Myocardial cell injury in septic shock

Critical Care Medicine

Volumn 27, Issue 9, 1999, Pages 1775-1780

  Turner, Andrew ^a   Tsamitros, Mary ^a   Bellomo, Rinaldo ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Acute Physiology and Chronic Health Evaluation (APACHE) II; Cardiac troponin I; Catecholamine; Creatine kinase; Lactate; Left ventricular stroke work index; Myocardial necrosis; Septic shock

Indexed keywords

LACTIC ACID; TROPONIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART STROKE VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE; LACTATE BLOOD LEVEL; LUNG VENTILATION; PRIORITY JOURNAL; SEPTIC SHOCK;

ADULT; AGED; APACHE; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CATECHOLAMINES; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LACTIC ACID; MIDDLE AGED; MYOCARDIUM; NECROSIS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TROPONIN I; VASOCONSTRICTOR AGENTS; VENTRICULAR FUNCTION, LEFT; VICTORIA;

EID: 0032871721     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199909000-00012     Document Type: Article

References (27)

1. 1. Ellrodt AG, Riedinger MS, Kimchi A, et al: Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J 1985; 110:402-409
2. 2. Cunnion RE, Schaer GL, Parker MM, et al: The coronary circulation in human septic shock. Circulation 1986; 73:637-644
3. 3. Ognibene FP, Parker MM, Natanson C, et al: Depressed left ventricular performance: Response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93: 903-910
4. 4. Solomon MA, Correa R, Alexander HR, et al: Myocardial energy metabolism and morphology in a canine model of sepsis. Am J Physiol 1994; 266:H757-H768
5. 5. Dhainaut JF, Huyghebaert MF, Monsallier JF, et al: Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987; 75:533-541
6. 6. Parrillo JE: Pathogenic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
7. 7. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
8. 8. Schenk EA, Moss AJ: Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res 1966; 18:605-615
9. 9. Szakacs JE, Mehlman B: Pathologic changes induced by L-norepinephrine: Quantitative aspects. Am J Cardiol 1960; 5:619-627
10. 10. Adams JE, Schechtman KB, Landt Y, et al: Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291-1295
11. 11. Mair J, Morandell D, Genser N, et al: Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995; 41:1266-1272
12. 12. Antman EM, Tanasijevic MJ, Thompson B, et al: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-1349
13. 13. Adams JE, Bodor GS, Davila-Roman VG, et al: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88:101-106
14. 14. Hafner G, Thome-Kromer B, Schaube J: Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40:1790-1791
15. 15. McLaurin MD, Apple FS, Voss EM, et al: Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischaemic heart disease: Evidence of troponin T expression in skeletal muscle. Clin Chem 1997; 43:976-982
16. 16. Adams JE, Sicard GA, Allen BT, et al: Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670-674
17. 17. Adams JE, Abendschein DR, Jaffe AS: Biochemical markers of myocardial injury: Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88:750-763
18. 18. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
19. 19. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
20. 20. Matthews JN, Altman DG, Campbell MJ, et al: Analysis of serial measurements in medical research. BMJ 1990; 300:230-235
21. 21. Adams JE, Davila-Roman VG, Bessey PQ, et al: Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 1996; 131:308-312
22. 22. Missov E, Calzolari C, Pau B: Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997; 96:2953-2958
23. 23. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
24. 24. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
25. 25. Desjars P, Pinaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15: 134-137
26. 26. Bollaert PE, Bauer P, Audibert G, et al: Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock. Chest 1990; 98:949-953
27. 27. Guest TM, Ramanathan AV, Tuteur PG, et al: Myocardial injury in critically ill patients: A frequently unrecognized complication. JAMA 1995; 273:1945-1949